Concepedia

Complete hematologic remissions in chronic-phase, philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine

Alan Saven, Lawrence D. Piro, Robert H. Lemon, Michael L. Figueroa, Michael P. Kosty, Douglas J. Ellison, Ernest Beutler

Cancer · 1994 · 31 citations · 30 references

DOIFull text

Open access

Abstract

2-CdA is active in CML, inducing complete hematologic responses, but the absence of cytogenetic responses and severe immunosuppression may limit its clinical use.

References

30

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.4K citations

, , +14

ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY

E.R. Giblett, JeanneE. Anderson, Flossie Cohen et al. · The Lancet · 1972 · 1.7K citations

, , +7

Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase

John M. Goldman, Robert Peter Gale, Mary M. Horowitz et al. · Annals of Internal Medicine · 1988 · 862 citations

Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

Jorge R. Quesada, James M. Reuben, John T. Manning et al. · New England Journal of Medicine · 1984 · 834 citations

Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha<sub>A</sub>in Chronic Myelogenous Leukemia

Moshe Talpaz, Hagop M. Kantarjian, Kenneth B. McCredie et al. · New England Journal of Medicine · 1986 · 657 citations